1
|
Cardoso RV, Pereira PR, Freitas CS, Mattos ÉBDA, Silva AVDF, Midlej VDV, Vericimo MA, Conte-Júnior CA, Paschoalin VMF. Tarin-Loaded Nanoliposomes Activate Apoptosis and Autophagy and Inhibit the Migration of Human Mammary Adenocarcinoma Cells. Int J Nanomedicine 2023; 18:6393-6408. [PMID: 37954458 PMCID: PMC10638905 DOI: 10.2147/ijn.s434626] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/09/2023] [Accepted: 10/28/2023] [Indexed: 11/14/2023] Open
Abstract
Background Tarin, a lectin purified from Colocasia esculenta, promotes in vitro and in vivo immunomodulatory effects allied to promising anticancer and antimetastatic effects against human adenocarcinoma mammary cells. This makes this 47 kDa-protein a natural candidate against human breast cancer, a leading cause of death among women. Tarin encapsulated in pegylated nanoliposomes displays increased effectiveness in controlling the proliferation of a mammary adenocarcinoma lineage comprising MDA-MB-231 cells. Methods The mechanisms enrolled in anticancer and antimetastatic responses were investigated by treating MDA-MB-231 cells with nano-encapsulated tarin at 72 μg/mL for up to 48h through flow cytometry and transmission electron microscopy (TEM). The safety of nano-encapsulated tarin towards healthy tissue was also assessed by the resazurin viability assay, and the effect of nanoencapsulated tarin on cell migration was evaluated by scratch assays. Results Ultrastructural analyses of MDA-MB-231 cells exposed to nanoencapsulated tarin revealed the accumulation of autophagosomes and damaged organelles, compatible with autophagy-dependent cell death. On the other hand, the flow cytometry investigation detected the increased occurrence of acidic vacuolar organelles, a late autophagosome trait, along with the enhanced presence of apoptotic cells, activated caspase-3/7, and cell cycle arrest at G0/G1. No deleterious effects were observed in healthy fibroblast cells following tarin nanoencapsulated exposition, in contrast to reduced viability in cells exposed to free tarin. The migration of MDA-MB-231 cells was inhibited by nano-encapsulated tarin, with delayed movement by 24 h compared to free tarin. Conclusion The nanoliposome formulation delivers tarin in a delayed and sustained manner, as evidenced by the belated and potent antitumoral and anti-migration effects on adenocarcinoma cells, with no toxicity to healthy cells. Although further investigations are required to fully understand antitumorigenic tarin mechanisms, the activation of both apoptotic and autophagic machineries along with the caspase-3/7 pathway, and cell cycle arrest may comprise a part of these mechanisms.
Collapse
Affiliation(s)
- Raiane Vieira Cardoso
- Departamento de Bioquímica, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil
| | | | - Cyntia Silva Freitas
- Departamento de Bioquímica, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil
| | | | | | | | | | | | | |
Collapse
|
2
|
Zhang W, Huang G. Preparation, structural characteristics, and application of taro polysaccharides in food. JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE 2022; 102:6193-6201. [PMID: 35679352 DOI: 10.1002/jsfa.12058] [Citation(s) in RCA: 14] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/06/2022] [Revised: 05/18/2022] [Accepted: 06/09/2022] [Indexed: 06/15/2023]
Abstract
Taro, a staple food for residents in Africa and parts of Asia, is an important source of carbohydrate. China has abundant taro resources. Taro contains polysaccharide, vitamins, minerals and other substances. Taro polysaccharides, as a significant active ingredient in taro, are mainly composed of monosaccharide units such as glucose, galactose, arabinose, mannose, and so on. Taro polysaccharides have antioxidant, lipid-lowering, and immunomodulatory effects. In today's world, people are interested in food containing natural ingredients, which stimulates the potential of taro polysaccharides in the food, pharmaceutical, medical, and other fields. Herein, the extraction and purification, structural characterization, functional activity, and application of taro polysaccharides are reviewed to strengthen the cognition of taro polysaccharides. It provides references for further research and development of taro polysaccharides. © 2022 Society of Chemical Industry.
Collapse
Affiliation(s)
- Wenting Zhang
- Key Laboratory of Carbohydrate Science and Engineering, Chongqing Key Laboratory of Green Synthesis and Application, Chongqing Normal University, Chongqing, China
| | - Gangliang Huang
- Key Laboratory of Carbohydrate Science and Engineering, Chongqing Key Laboratory of Green Synthesis and Application, Chongqing Normal University, Chongqing, China
| |
Collapse
|
3
|
Kundu N, Ma X, Hoag S, Wang F, Ibrahim A, Godoy-Ruiz R, Weber DJ, Fulton AM. An Extract of Taro ( Colocasia esculenta) Mediates Potent Inhibitory Actions on Metastatic and Cancer Stem Cells by Tumor Cell-Autonomous and Immune-Dependent Mechanisms. BREAST CANCER-BASIC AND CLINICAL RESEARCH 2021; 15:11782234211034937. [PMID: 34376983 PMCID: PMC8320546 DOI: 10.1177/11782234211034937] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 12/18/2020] [Accepted: 07/07/2021] [Indexed: 11/17/2022]
Abstract
The taro plant, Colocasia esculenta, contains bioactive proteins with potential as cancer therapeutics. Several groups have reported anti-cancer activity in vitro and in vivo of taro-derived extracts (TEs). We reported that TE inhibits metastasis in a syngeneic murine model of Triple-Negative Breast Cancer (TNBC). Purpose We sought to confirm our earlier studies in additional models and to identify novel mechanisms by which efficacy is achieved. Methods We employed a panel of murine and human breast and ovarian cancer cell lines to determine the effect of TE on tumor cell viability, migration, and the ability to support cancer stem cells. Two syngeneic models of TNBC were employed to confirm our earlier report that TE potently inhibits metastasis. Cancer stem cell assays were employed to determine the ability of TE to inhibit tumorsphere-forming ability and to inhibit aldehyde dehydrogenase activity. To determine if host immunity contributes to the mechanism of metastasis inhibition, efficacy was assessed in immune-compromised mice. Results We demonstrate that viability of some, but not all cell lines is inhibited by TE. Likewise, tumor cell migration is inhibited by TE. Using 2 immune competent, syngeneic models of TNBC, we confirm our earlier findings that tumor metastasis is potently inhibited by TE. We also demonstrate, for the first time, that TE directly inhibits breast cancer stem cells. Administration of TE to mice elicits expansion of several spleen cell populations but it was not known if host immune cells contribute to the mechanism by which TE inhibits tumor cell dissemination. In novel findings, we now show that the ability of TE to inhibit metastasis relies on immune T-cell-dependent, but not B cell or Natural Killer (NK)-cell-dependent mechanisms. Thus, both tumor cell-autonomous and host immune factors contribute to the mechanisms underlying TE efficacy. Our long-term goal is to evaluate TE efficacy in clinical trials. Most of our past studies as well as many of the results reported in this report were carried out using an isolation protocol described earlier (TE). In preparation for a near future clinical trial, we have now developed a strategy to isolate an enriched taro fraction, TE-method 2, (TE-M2) as well as a more purified subfraction (TE-M2F1) which can be scaled up under Good Manufacturing Practice (GMP) conditions for evaluation in human subjects. We demonstrate that TE-M2 and TE-M2F1 retain the anti-metastatic properties of TE. Conclusions These studies provide further support for the continued examination of biologically active components of Colocasia esculenta as potential new therapeutic entities and identify a method to isolate sufficient quantities under GMP conditions to conduct early phase clinical studies.
Collapse
Affiliation(s)
- Namita Kundu
- Department of Pathology, University of Maryland School of Medicine, Baltimore, MD, USA.,University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA
| | - Xinrong Ma
- University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA
| | - Stephen Hoag
- University of Maryland School of Pharmacy, Baltimore, MD, USA
| | - Fang Wang
- University of Maryland School of Pharmacy, Baltimore, MD, USA
| | - Ahmed Ibrahim
- University of Maryland School of Pharmacy, Baltimore, MD, USA
| | - Raquel Godoy-Ruiz
- University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.,Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD, USA.,Center for Biological Therapeutics (CBT), University of Maryland School of Medicine, Baltimore, MD, USA.,Institute for Bioscience and Biotechnology Research (IBBR), Rockville, MD, USA
| | - David J Weber
- University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.,Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD, USA.,Center for Biological Therapeutics (CBT), University of Maryland School of Medicine, Baltimore, MD, USA.,Institute for Bioscience and Biotechnology Research (IBBR), Rockville, MD, USA
| | - Amy M Fulton
- Department of Pathology, University of Maryland School of Medicine, Baltimore, MD, USA.,University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.,VA Administration Investigator, VA Health Services Research and Development Service, Baltimore Veterans Administration Medical Center, Baltimore, MD, USA
| |
Collapse
|
4
|
Mattos EBDA, Pereira PR, Mérida LAD, Corrêa ACNTF, Freire MPV, Paschoalin VMF, Teixeira GAPB, Pinho MDFB, Verícimo MA. Taro Lectin Can Act as a Cytokine-Mimetic Compound, Stimulating Myeloid and T Lymphocyte Lineages and Protecting Progenitors in Murine Bone Marrow. Pharmaceutics 2021; 13:pharmaceutics13030350. [PMID: 33800086 PMCID: PMC8001523 DOI: 10.3390/pharmaceutics13030350] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/03/2021] [Revised: 02/26/2021] [Accepted: 03/03/2021] [Indexed: 11/29/2022] Open
Abstract
Taro (Colocasia esculenta) corm is traditionally consumed as a medicinal plant to stimulate immune responses and restore a health status. Tarin, a taro lectin, is considered responsible for the immunomodulatory effects of taro. In the present study, in order to investigate the effects of tarin on bone marrow hematopoietic population, murine cells were stimulated with tarin combined with a highly enriched conditioned medium containing either IL-3 or GM-CSF. Cells challenged with tarin proliferated in a dose-dependent manner, evidenced by the increase in cell density and number of clusters and colonies. Tarin exhibited a cytokine-mimetic effect similar to IL-3 and GM-CSF, increasing granulocytic cell lineage percentages, demonstrated by an increase in the relative percentage of Gr-1+ cells. Tarin does not increase lymphocytic lineages, but phenotyping revealed that the relative percentage of CD3+ cells was increased with a concomitant decrease in CD19+ and IL-7Rα+ cells. Most bone marrow cells were stained with tarin-FITC, indicating non-selective tarin binding, a phenomenon that must still be elucidated. In conclusion, taro corms contain an immunomodulatory lectin able to boost the immune system by promoting myeloid and lymphoid hematopoietic progenitor cell proliferation and differentiation.
Collapse
Affiliation(s)
- Erika Bertozzi de Aquino Mattos
- Biology Institute, Federal University (UFF), Rua Alexandre Moura, No. 8, Bloco M, Sala. 505, Gragoatá, Niterói, RJ 24210-200, Brazil; (E.B.d.A.M.); (L.A.D.M.); (M.P.V.F.); (G.A.P.B.T.); (M.d.F.B.P.); (M.A.V.)
| | - Patricia Ribeiro Pereira
- Chemistry Institute, Federal University of Rio de Janeiro (UFRJ), Av. Athos da Silveira Ramos, 149, Sala 545, Cidade Universitária, Rio de Janeiro, RJ 21941-909, Brazil; (P.R.P.); (A.C.N.T.F.C.)
| | - Lyris Anunciata Demétrio Mérida
- Biology Institute, Federal University (UFF), Rua Alexandre Moura, No. 8, Bloco M, Sala. 505, Gragoatá, Niterói, RJ 24210-200, Brazil; (E.B.d.A.M.); (L.A.D.M.); (M.P.V.F.); (G.A.P.B.T.); (M.d.F.B.P.); (M.A.V.)
| | - Anna Carolina Nitzsche Teixeira Fernandes Corrêa
- Chemistry Institute, Federal University of Rio de Janeiro (UFRJ), Av. Athos da Silveira Ramos, 149, Sala 545, Cidade Universitária, Rio de Janeiro, RJ 21941-909, Brazil; (P.R.P.); (A.C.N.T.F.C.)
| | - Maria Paula Vigna Freire
- Biology Institute, Federal University (UFF), Rua Alexandre Moura, No. 8, Bloco M, Sala. 505, Gragoatá, Niterói, RJ 24210-200, Brazil; (E.B.d.A.M.); (L.A.D.M.); (M.P.V.F.); (G.A.P.B.T.); (M.d.F.B.P.); (M.A.V.)
| | - Vania Margaret Flosi Paschoalin
- Chemistry Institute, Federal University of Rio de Janeiro (UFRJ), Av. Athos da Silveira Ramos, 149, Sala 545, Cidade Universitária, Rio de Janeiro, RJ 21941-909, Brazil; (P.R.P.); (A.C.N.T.F.C.)
- Correspondence: ; Tel.: +55-(21)-3938-7362
| | - Gerlinde Agate Platais Brasil Teixeira
- Biology Institute, Federal University (UFF), Rua Alexandre Moura, No. 8, Bloco M, Sala. 505, Gragoatá, Niterói, RJ 24210-200, Brazil; (E.B.d.A.M.); (L.A.D.M.); (M.P.V.F.); (G.A.P.B.T.); (M.d.F.B.P.); (M.A.V.)
| | - Maria de Fátima Brandão Pinho
- Biology Institute, Federal University (UFF), Rua Alexandre Moura, No. 8, Bloco M, Sala. 505, Gragoatá, Niterói, RJ 24210-200, Brazil; (E.B.d.A.M.); (L.A.D.M.); (M.P.V.F.); (G.A.P.B.T.); (M.d.F.B.P.); (M.A.V.)
| | - Maurício Afonso Verícimo
- Biology Institute, Federal University (UFF), Rua Alexandre Moura, No. 8, Bloco M, Sala. 505, Gragoatá, Niterói, RJ 24210-200, Brazil; (E.B.d.A.M.); (L.A.D.M.); (M.P.V.F.); (G.A.P.B.T.); (M.d.F.B.P.); (M.A.V.)
| |
Collapse
|
5
|
Anticancer and Immunomodulatory Benefits of Taro ( Colocasia esculenta) Corms, an Underexploited Tuber Crop. Int J Mol Sci 2020; 22:ijms22010265. [PMID: 33383887 PMCID: PMC7795958 DOI: 10.3390/ijms22010265] [Citation(s) in RCA: 13] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/19/2020] [Revised: 12/21/2020] [Accepted: 12/21/2020] [Indexed: 12/20/2022] Open
Abstract
Taro corms contain valuable bioactive molecules effective against cancer and cancer-related risk factors, such as carcinogens and biological agents, several pathophysiological conditions, including oxidative stress and inflammation, while controlling metabolic dysfunctions and boosting the immunological response. Such broad effects are achieved by the taro health-influencing compounds displaying antitumoral, antimutagenic, immunomodulatory, anti-inflammatory, antioxidant, anti-hyperglycemic, and anti-hyperlipidemic activities. Taro bioactivities are attributed to the combination of tarin, taro-4-I polysaccharide, taro polysaccharides 1 and 2 (TPS-1 and TPS-2), A-1/B-2 α-amylase inhibitors, monogalactosyldiacylglycerols (MGDGs), digalactosyldiacylglycerols (DGDGs), polyphenols, and nonphenolic antioxidants. Most of these compounds have been purified and successfully challenged in vitro and in vivo, proving their involvement in the aforementioned activities. Although these health-promoting effects have been recognized since ancient times, as well as other valuable features of taro for food profit, such as hypo-allergenicity, gluten-free, and carbohydrates with medium-glycemic index, taro crop remains underexploited. The popularization of taro intake should be considered a dietary intervention strategy to be applied to improve the overall health status of the organism and as supportive therapy to manage tumorigenesis.
Collapse
|
6
|
Corrêa ACNTF, Vericimo MA, Dashevskiy A, Pereira PR, Paschoalin VMF. Liposomal Taro Lectin Nanocapsules Control Human Glioblastoma and Mammary Adenocarcinoma Cell Proliferation. Molecules 2019; 24:E471. [PMID: 30699910 PMCID: PMC6385085 DOI: 10.3390/molecules24030471] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/22/2018] [Revised: 01/18/2019] [Accepted: 01/23/2019] [Indexed: 12/14/2022] Open
Abstract
The search for natural anticancer agents and nanocarrier uses are a part of the current strategies to overcome the side effects caused by chemotherapeutics. Liposomal nanocapsules loaded with purified tarin, a potential immunomodulatory and antitumoral lectin found in taro corms, were produced. Liposomes were composed by 1,2-dioleoyl-sn-glycerol-3-phosphoethanolamine, cholesterylhemisuccinate, and 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[folate(polyethylene glycol)-2000 prepared by thin-film hydration. Small unilamellar vesicles were achieved by sonication and extrusion. Scanning electron microscopy evidenced round-shaped nanocapsules presenting a smooth surface, 150 nm diameter and polydispersity index <0.2, estimated by dynamic light scattering. Tarin entrapment rates were over 80% and leakage of ~3% under 40 days of storage at 4 °C. Entrapped tarin exhibited an 83% release after 6 h at pH 4.6⁻7.4 and 36 °C. Both free and encapsulated tarin exhibited no in vitro toxicity against healthy mice bone marrow and L929 cells but stimulated the production of fibroblast-like and large round-shaped cells. Encapsulated tarin resulted in inhibition of human glioblastoma (U-87 MG) and breast adenocarcinoma (MDA-MB-231) proliferation, with an IC50 of 39.36 and 71.38 µg/mL, respectively. The effectiveness of encapsulated tarin was similar to conventional chemotherapy drugs, such as cisplatin and temozolide. Tarin liposomal nanocapsules exhibited superior pharmacological activity compared to free tarin as a potential chemotherapy adjuvant.
Collapse
Affiliation(s)
- Anna C N T F Corrêa
- Chemistry Institute, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-909, Brazil.
| | - Mauricio A Vericimo
- Immunobiology Department, Universidade Federal Fluminense, Niterói 24020-150, Brazil.
| | - Andriy Dashevskiy
- Pharmaceutical Technology Department, Freie Universität Berlin, 12169 Berlin, Germany.
| | - Patricia R Pereira
- Chemistry Institute, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-909, Brazil.
| | - Vania M F Paschoalin
- Chemistry Institute, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-909, Brazil.
| |
Collapse
|